DEC 13, 2020 8:24 AM PST

Potential Treatment for Common Cause of Heart Disease is ID'ed

WRITTEN BY: Carmen Leitch

The most common cause of heart disease in elderly people is calcific aortic valve disease, in which calcium builds up in the valves and vessels of the heart, causing them to harden over time. As it happens, the blood flow out of the heart is obstructed and the heart eventually fails. There are few treatment options; patients must wait for the vessels or valves to be so hard that they can be replaced. Reporting in Science, researchers may now have a potential therapeutic.

Image credit: Myriams-Fotos/Pixabay

"The disease is often diagnosed at an early stage and calcification of the heart valves worsens over the patient's lifetime as they age," said study leader, Gladstone President and Director of the Roddenberry Stem Cell Center Deepak Srivastava, M.D. "If we could intervene early in life with an effective drug, we could potentially prevent the disease from occurring. By simply slowing the progression and shifting the age of people who require interventions by five or ten years, we could avoid tens of thousands of surgical valve replacements every year."

About one or two percent of Americans have a congenital heart defect called a bicuspid aortic valve (in which there are only two instead of the normal three leaflets on the aortic valve), and many carriers will not know until their forties or later. "About a third of patients with bicuspid aortic valve, which is a very large number, will develop enough calcification to require an intervention," explained Srivastava.

Previous work has shown that mutations in a gene called NOTCH1 cause about four percent of cases of calcific aortic valve disease, while the rest are sporadic - there is no known genetic cause.

"The NOTCH1 mutation provided a foothold for us to figure out what goes wrong in this common disease, but most people won't have that mutation," noted Srivastava. "However, we found that the process that leads to the calcification of the valve is mostly the same whether individuals have the mutation or not. The valve cells get confused and start thinking they're bone cells, so they start laying down calcium and that leads to hardening and narrowing of the valves."

The researchers wanted to find a treatment that could work for patients with NOTCH1 mutations as wells patient with sporadic cases of the disease, so they began by searching for genes whose expression changes in diseased cells. These genes were then placed in a network using computational tools. Next, the scientists assessed the impact of about 1,600 drugs on this network. They found a few that could shift the disease network back toward a healthy state.

The candidate molecules were tested on cell lines derived from 20 patients with sporadic cases of aortic valve calcification. They found one that worked not only against these cases, but also against cases involving NOTCH1 mutations.

The researchers confirmed that the drug was effective in preventing and treating aortic valve disease in a mouse model; it could prevent the disease before onset, halt disease progression in ongoing cases, and sometimes even reversed it. Most human patients are diagnosed after the disease is already calcifying structures, so this work may be especially useful.

"Our strategy to identify gene network-correcting therapies that treat the core disease mechanism may represent a compelling path for drug discovery in a range of other human diseases," said lead study author Christina V. Theodoris, MD, PhD. "Many therapeutics found in the lab don't translate well to humans or focus only on a specific symptom. We hope our approach can offer a new direction that could increase the likelihood of candidate therapies being effective in patients."

Sources: AAAS/Eurekalert! via Gladstone Institutes, Science

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 20, 2020
Cardiology
Investigating a New Method in Heart Repair
OCT 20, 2020
Investigating a New Method in Heart Repair
Cardiovascular disease is a widespread issue that affects millions across the world. One of the most common of these dis ...
OCT 23, 2020
Clinical & Molecular DX
Follow Your Heart: A Genetic Predictor of Cardiovascular Disease
OCT 23, 2020
Follow Your Heart: A Genetic Predictor of Cardiovascular Disease
Cardiovascular disease is the leading cause of death globally, resulting in the loss of nearly 18 million lives each yea ...
JAN 09, 2021
Cannabis Sciences
Cannabis Use Does not Increase Risk of Heart Disease
JAN 09, 2021
Cannabis Use Does not Increase Risk of Heart Disease
Previous studies on how cannabis affects cardiovascular health have delivered mixed results. Now, from a study of over 5 ...
MAY 01, 2021
Cannabis Sciences
Early Use of Cannabis Linked to Heart Disease
MAY 01, 2021
Early Use of Cannabis Linked to Heart Disease
While the dangers of cigarette smoking to cardiovascular health are widely known, those for cannabis have been less rese ...
MAY 02, 2021
Microbiology
Fasting Alters Gut Microbiota, Lowering Blood Pressure
MAY 02, 2021
Fasting Alters Gut Microbiota, Lowering Blood Pressure
Increasingly, microbes in the gut are being linked to human health and disease. New research has suggested that disrupti ...
MAY 03, 2021
Cardiology
Task Force IDs 7 Costly Medical Procedures With No Benefit
MAY 03, 2021
Task Force IDs 7 Costly Medical Procedures With No Benefit
Researchers have identified a surprising number of health screens that are given to patients who may not need them. Thes ...
Loading Comments...